🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 17322U207
- Market Cap
- Small Cap
Business: Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in oncology, adjunct cancer care, stem cell therapy and unique prescription products. The Company seeks to achieve leading market positions by providing therapeutic products that address unmet medical needs. By using previously approved drugs with substantial safety and efficacy data, Citius seeks to reduce the risks associated with pharmaceutical product development and regulatory requirements.
Company Contact
- CEO
- Leonard Mazur
- CFO
- Jaime Bartushak
- Headquarters
- 11 Commerce Drive, First Floor, Cranford, NJ 07016
- Phone
- 908-967-6677
- Investor Relations
- Andrew Scott · 908-967-6677 · ascott@citiuspharma.com